Yearly Archives: 2017

Forge Therapeutics to present new data on novel Gram-negative antibiotic program at ASM Microbe 2017

San Diego, California, May 24, 2017 – Forge Therapeutics, Inc., (Forge), a biotechnology company discovering first-in-class antibiotics using a breakthrough drug discovery platform, ...

Forge Therapeutics to present new data on novel Gram-negative antibiotic program at ASM Microbe 20172017-10-09T17:08:34-07:00

Forge Therapeutics attracts biotechnology leaders to join expanded board of directors

Board Composed of San Diego Biotech Veterans, Global Drug Development & Corporate Finance Leaders San Diego, California, May 16, 2017 – Forge Therapeutics, ...

Forge Therapeutics attracts biotechnology leaders to join expanded board of directors2017-10-09T22:02:22-07:00

Forge Therapeutics raises $15m Series A financing to develop first novel Gram-negative antibiotic in decades

Series A Complements Recent CARB-X Non-Dilutive Funding Forge Is Resourced And Financed Into The Clinic  San Diego, California, April 25, 2017 – Forge ...

Forge Therapeutics raises $15m Series A financing to develop first novel Gram-negative antibiotic in decades2017-10-11T16:20:04-07:00

Quest for new antibiotics gets first major funding from global partnership

A major global partnership aimed at fighting superbugs announced Thursday that it is investing up to $48 million in research projects, including potentially ...

Quest for new antibiotics gets first major funding from global partnership2017-10-09T18:08:07-07:00

Forge Therapeutics Wins Powered by CARB-X Research Award of $8.8M to Accelerate Development of its LpxC Antibiotic to Kill the World’s Deadliest ‘Superbugs’

San Diego, Calif., March 30, 2017 – Forge Therapeutics, Inc., (“Forge”), a biotechnology company discovering first-in-class antibiotics using a breakthrough drug discovery platform, ...

Forge Therapeutics Wins Powered by CARB-X Research Award of $8.8M to Accelerate Development of its LpxC Antibiotic to Kill the World’s Deadliest ‘Superbugs’2017-10-09T22:04:13-07:00

Forge Therapeutics to Present at Biocom Global Life Science Partnering Conference

Company to discuss novel antibiotic program targeting LpxC to kill Gram-negative superbugs  San Diego, Calif., February 28, 2017 – Forge Therapeutics, Inc., a ...

Forge Therapeutics to Present at Biocom Global Life Science Partnering Conference2017-10-09T17:16:04-07:00
Load More Posts
Go to Top